EG00229

Code: SML1367-25MG D2-231

Biochem/physiol Actions

EG00229 is an antagonist of the VEGF-A receptor neuropilin 1 (NRP1), which decreases viability of A549 lung carcinoma cells. EG00229 impairs VEGFA ind...


read more

Your Price
€815.74 25MG
€1,003.36 inc. VAT
REQUEST

Biochem/physiol Actions

EG00229 is an antagonist of the VEGF-A receptor neuropilin 1 (NRP1), which decreases viability of A549 lung carcinoma cells. EG00229 impairs VEGFA induced migration of HUV-EC-C endothelial cells.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
color, pale yellow to yellow-orange
formpowder
InChI keyZWWMEDURALZMEV-NSHDSACASA-N
InChI1S/C17H19N7O5S3/c18-17(19)20-7-2-4-11(16(26)27)21-15(25)14-10(6-8-30-14)24-32(28,29)12-5-1-3-9-13(12)23-31-22-9/h1,3,5-6,8,11,24H,2,4,7H2,(H,21,25)(H,26,27)(H4,18,19,20)/t11-/m0/s1
Quality Level100
SMILES stringO=C(N[C@H](C(O)=O)CCCNC(N)=N)C1=C(C=CS1)NS(C2=CC=CC3=NSN=C32)(=O)=O
solubilityDMSO: 20 mg/mL, clear
storage temp.2-8°C
Cas Number1018927-63-3
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.